Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Clinical trial NCT06495125 · RECRUITING

Trial details

NCT number: NCT06495125
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Lung Adenocarcinoma Refractory Lung Adenocarcinoma Stage III Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8

Start date: 2024-07-31
Primary completion: 2029-03-17
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.